Immune checkpoint markers and tumour mutation burden in Wilms tumour: A study of 59 cases

Authors

Aidas J Mattis, Washington University School of Medicine in St. Louis
Jie-Fu Chen, Washington University School of Medicine in St. Louis
Ivan A Gonzalez, Washington University School of Medicine in St. Louis
Rehan Rais, Washington University School of Medicine in St. Louis
Louis P Dehner, Washington University School of Medicine in St. Louis
John Pfeifer, Washington University School of Medicine in St. Louis
Mai He, Washington University School of Medicine in St. Louis

Journal

Pathology

Publication Date

10-1-2024

Volume

56

Issue

6

First Page

814

Last Page

825

Document Type

Open Access Publication

DOI

10.1016/j.pathol.2024.03.005

Rights and Permissions

Mattis AJ, Chen JF, Gonzalez IA, Rais R, Dehner LP, Pfeifer J, He M. Immune checkpoint markers and tumour mutation burden in Wilms tumour: a study of 59 cases. Pathology. 2024 Oct;56(6):814-825. doi: 10.1016/j.pathol.2024.03.005. © 2025 The Authors. Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Mattis, Aidas J; Chen, Jie-Fu; Gonzalez, Ivan A; Rais, Rehan; Dehner, Louis P; Pfeifer, John; and He, Mai, "Immune checkpoint markers and tumour mutation burden in Wilms tumour: A study of 59 cases." Pathology. 56, 6. 814 - 825. (2024).
https://digitalcommons.wustl.edu/oa_4/5890

Department

ICTS (Institute of Clinical and Translational Sciences)